Insider Stock Trading History of Sobel Burton E


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Sobel Burton E since year 2005. The trader's CIK number is 1196855. At the time of this reporting, Sobel Burton E is the Director of Ariad Pharmaceuticals Inc . (stock ticker symbol ARIA). See this page for all insider trading activities at Ariad Pharmaceuticals Inc .

Note that in the past SOBEL BURTON E also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Sobel Burton E since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2008-01-17 ARIA Ariad Pharmaceuticals Inc Option Ex 10,000 .00 0
2007-01-19 NRPH New River Pharmaceuticals Inc Option Ex 5,000 32.71 163,550
2007-01-19 NRPH New River Pharmaceuticals Inc Sale 5,000 56.10 280,515
2007-01-03 NRPH New River Pharmaceuticals Inc Option Ex 2,500 11.60 29,000
2007-01-03 NRPH New River Pharmaceuticals Inc Sale 2,500 54.83 137,077
2006-12-01 NRPH New River Pharmaceuticals Inc Sale 7,500 49.01 367,567
2006-12-01 NRPH New River Pharmaceuticals Inc Option Ex 7,500 11.60 87,000
2006-11-10 NUVO Nuvelo Inc Option Ex 12,500 6.50 81,250
2006-11-10 NUVO Nuvelo Inc Sale 12,500 18.17 227,125
2006-08-10 NUVO Nuvelo Inc Option Ex 12,500 6.50 81,250
2006-08-10 NUVO Nuvelo Inc Sale 12,500 16.00 200,000
2006-05-25 NUVO Nuvelo Inc Sale 3,900 15.58 60,769
2006-05-26 NUVO Nuvelo Inc Sale 8,600 15.59 134,048
2006-03-20 NRPH New River Pharmaceuticals Inc Option Ex 20,000 11.60 232,000
2006-03-20 NRPH New River Pharmaceuticals Inc Sale 20,000 30.86 617,140
2006-01-18 ARIA Ariad Pharmaceuticals Inc Sale 4,147 6.50 26,955
2006-01-09 ARIA Ariad Pharmaceuticals Inc Sale 5,853 6.50 38,044

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sobel Burton E (Director of Ariad Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.